Injectable GHK-Cu has a thinner evidence base much of what has been published is preclinical, with isolated clinical reports
Takahashi-Kanemitsu A, Lu M, Knight CT, Yamamoto T, Hayashi T, Mii Y, et al
These may include innovative delivery systems and formulations
Introduction GHK-Cu is a naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine complexed with copper(II)) that has become a recurring subject in preclinical studies of wound repair and extracellular matrix (ECM) biology
Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application
Always consult with your primary care physician or our clinical partners at Celia Health to undergo proper medical screening before beginning any peptide therapy